AstroNova's Q3 Net Income Jumps 57% Despite Revenue Dip, Goodwill Hit

TL;DR

**AstroNova's Q3 net income surge is a mirage; the nine-month loss and goodwill impairment signal deeper issues, making this a sell.**

AI Summary

AstroNova, Inc. reported a mixed financial performance for the three and nine months ended October 31, 2025. For the three-month period, revenue decreased by 3.1% to $39.169 million from $40.422 million in the prior year, yet net income increased significantly to $0.378 million from $0.240 million, a 57.5% rise. This improvement in net income was despite a goodwill impairment charge of $0.297 million. However, for the nine-month period, the company experienced a net loss of $1.242 million, a stark contrast to the net income of $1.110 million in the comparable prior period, primarily due to higher operating expenses, including a $0.297 million goodwill impairment, and increased interest expense of $2.609 million. Total assets decreased to $140.833 million from $145.595 million at January 31, 2025, while total liabilities also decreased to $63.953 million from $69.845 million. The Product ID segment, which includes the MTEX acquisition, accounts for approximately 80% of its revenue from recurring supplies, parts, and service, indicating a stable revenue stream despite overall revenue decline. The company also corrected an immaterial error related to the MTEX acquisition, writing off Euro 1.8 million in non-existent or obsolete PP&E, which increased goodwill.

Why It Matters

AstroNova's mixed results highlight the challenges of integrating acquisitions while managing core business performance. The significant increase in Q3 net income, despite a revenue decline and goodwill impairment, suggests effective cost management or strong performance in specific areas, which could be a positive signal for investors. However, the nine-month net loss raises concerns about sustained profitability and the long-term impact of increased interest expenses and acquisition-related adjustments. For employees, the integration of MTEX and the segment name change to 'Aerospace' indicate strategic shifts that could affect roles and opportunities. Customers might see new product offerings from the MTEX integration, particularly in flexible packaging and industrial printing, intensifying competition in those markets.

Risk Assessment

Risk Level: medium — The company reported a net loss of $1.242 million for the nine months ended October 31, 2025, a significant decline from a net income of $1.110 million in the prior year. This, coupled with a $0.297 million goodwill impairment charge and increased interest expense of $2.609 million, indicates financial strain and potential challenges in profitability and debt management.

Analyst Insight

Investors should exercise caution and conduct further due diligence on AstroNova, Inc. The nine-month net loss and goodwill impairment suggest underlying operational or integration issues, despite the positive Q3 net income. Consider the impact of increased interest expenses on future profitability and evaluate the long-term strategic benefits of the MTEX acquisition.

Financial Highlights

revenue

$39.169M

total Assets

$140.833M

net Income

$0.378M

revenue Growth

-3.1%

Revenue Breakdown

Key Numbers

• $39.169M — Revenue (3-month period, down 3.1% from $40.422M year-over-year)
• $0.378M — Net Income (3-month period, up 57.5% from $0.240M year-over-year)
• ($1.242M) — Net Loss (9-month period, compared to $1.110M net income in prior year)
• $0.297M — Goodwill Impairment (recorded in the three and nine months ended October 31, 2025)
• $2.609M — Interest Expense (9-month period, up from $2.363M in prior year)
• $140.833M — Total Assets (as of October 31, 2025, down from $145.595M at January 31, 2025)
• $63.953M — Total Liabilities (as of October 31, 2025, down from $69.845M at January 31, 2025)
• 80% — Product ID Recurring Revenue (percentage of segment revenue from supplies, parts, and service)
• Euro 1.8 million — PP&E Write-off (immaterial error correction related to MTEX acquisition)
• 7,638,423 — Common Shares Outstanding (as of December 5, 2025)

Key Players & Entities

• AstroNova, Inc. (company) — registrant
• MTEX New Solution, S.A. (company) — acquired company
• Product ID (company) — business segment
• Aerospace (company) — business segment
• $39.169 million (dollar_amount) — revenue for three months ended October 31, 2025
• $40.422 million (dollar_amount) — revenue for three months ended November 2, 2024
• $0.378 million (dollar_amount) — net income for three months ended October 31, 2025
• $0.240 million (dollar_amount) — net income for three months ended November 2, 2024
• $1.242 million (dollar_amount) — net loss for nine months ended October 31, 2025
• $1.110 million (dollar_amount) — net income for nine months ended November 2, 2024

FAQ

Risk Factors

• Goodwill Impairment [medium — operational]: The company recorded a goodwill impairment charge of $0.297 million in the three and nine months ended October 31, 2025. This charge negatively impacted net income, particularly for the nine-month period where it contributed to a net loss of $1.242 million.
• PP&E Write-off [low — operational]: An immaterial error correction related to the MTEX acquisition involved writing off Euro 1.8 million in non-existent or obsolete PP&E. This adjustment increased goodwill, which may be subject to future impairment.
• Increased Interest Expense [medium — financial]: Interest expense for the nine-month period increased to $2.609 million from $2.363 million in the prior year. This rise in financing costs contributed to the net loss for the nine-month period.

Industry Context

AstroNova operates in markets that rely on specialized printing and data acquisition technologies. The company's Product ID segment, with its significant recurring revenue from supplies, parts, and service, suggests a focus on maintaining stable income streams through aftermarket support, which is crucial in industries with long product lifecycles.

Regulatory Implications

The company must ensure compliance with accounting standards, particularly regarding the recognition and valuation of assets and liabilities, as evidenced by the PP&E write-off and goodwill impairment. Accurate reporting of financial performance is critical for investor confidence and regulatory oversight.

What Investors Should Do

1. Monitor the performance of the Product ID segment
2. Analyze the impact of goodwill and potential future impairments
3. Evaluate the trend in operating expenses and interest expense

Key Dates

• 2025-10-31: End of the third quarter and nine-month period — Financial results for this period show a mixed performance with declining revenue but improved net income for the quarter, contrasted by a net loss for the nine months.
• 2025-01-31: Beginning of the fiscal year — Represents the prior balance sheet date, showing total assets of $145.595 million and total liabilities of $69.845 million.

Glossary

Goodwill Impairment

A reduction in the carrying value of goodwill on a company's balance sheet when its fair value is determined to be less than its carrying amount. This often occurs when an acquired company underperforms expectations. (A $0.297 million goodwill impairment charge was recorded, impacting net income for the period.)

PP&E

Property, Plant, and Equipment. These are long-term tangible assets used in a company's operations. (Euro 1.8 million of PP&E was written off as part of an error correction related to the MTEX acquisition.)

MTEX acquisition

Refers to the acquisition of a company named MTEX, which has had subsequent accounting adjustments. (An error correction related to this acquisition led to a PP&E write-off and an increase in goodwill.)

Year-Over-Year Comparison

Compared to the prior year, AstroNova reported a 3.1% decrease in revenue for the three months ended October 31, 2025, to $39.169 million. However, net income for the same period saw a substantial 57.5% increase to $0.378 million, partly due to a goodwill impairment charge. The nine-month period, however, shifted from net income to a net loss of $1.242 million, driven by higher operating and interest expenses, and a goodwill impairment.

Key Financial Figures

• $0.05 — on which registered Common Stock , $0.05 Par Value ALOT NASDAQ Global Market

Filing Documents

• alot-20251031.htm (10-Q) — 3372KB
• alot-ex10_7.htm (EX-10.7) — 53KB
• alot-ex31_1.htm (EX-31.1) — 17KB
• alot-ex31_2.htm (EX-31.2) — 17KB
• alot-ex32_1.htm (EX-32.1) — 11KB
• alot-ex32_2.htm (EX-32.2) — 11KB
• img214091994_0.jpg (GRAPHIC) — 75KB
• 0001193125-25-314060.txt ( ) — 14822KB
• alot-20251031.xsd (EX-101.SCH) — 1637KB
• alot-20251031_htm.xml (XML) — 3263KB

Financial Statements

Financial Statements Unaudited Condensed Consolidated Balance Sheets – October 31, 2025 and January 31, 2025 1 Unaudited Condensed Consolidated Statements of Income (Loss) – Three and Nine Months Ended October 31 , 2025 and November 2 2024 2 Unaudited Condensed Consolidated Statements of Comprehensive Income (Loss) – Three and Nine Months Ended October 31 , 2025 and November 2, 2024 3 Unaudited Condensed Consolidated Statements of Changes in Shareholders' Equity – Three and Nine Months Ended October 31 , 2025 and November 2 , 2024 4 Unaudited Condensed Consolidated Statements of Cash Flows – Nine Months Ended October 31 , 2025 and November 2 , 2024 5 Notes to the Condensed Consolidated Financial Statements (unaudited) 6 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 25 Item 3.

Quantitative and Qualitative Disclosures about Market Risk

Quantitative and Qualitative Disclosures about Market Risk 35 Item 4.

Controls and Procedures

Controls and Procedures 36 Part II. Other Information 36 Item 1.

Legal Proceedings

Legal Proceedings 36 Item 1A.

Risk Factors

Risk Factors 36 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 37 Item 6. Exhibits 39

Signatures

Signatures 40 Pa rt I. FINANCIAL INFORMATION It em 1. Financial Statements ASTRONOVA, INC. CONDENSED CONSOL IDATED BALANCE SHEETS (In Thousands, Except Share Data) October 31, 2025 January 31, 2025 (Unaudited) ASSETS CURRENT ASSETS Cash and Cash Equivalents $ 3,606 $ 5,050 Accounts Receivable, net 20,396 21,218 Inventories, net 45,124 47,894 Prepaid Expenses and Other Current Assets 5,022 3,855 Total Current Assets 74,148 78,017 Property, Plant and Equipment, net 14,709 15,793 Identifiable Intangibles, net 22,070 23,519 Goodwill 17,121 16,361 Deferred Tax Assets, net 8,565 8,431 Right of Use Asset 2,573 1,781 Other Assets 1,647 1,693 TOTAL ASSETS $ 140,833 $ 145,595 LIABILITIES AND SHAREHOLDERS' EQUITY CURRENT LIABILITIES Accounts Payable $ 7,402 $ 7,928 Accrued Compensation 4,036 3,745 Other Accrued Expenses 4,857 4,461 Revolving Line of Credit 18,146 20,929 Current Portion of Long-Term Debt 3,152 6,110 Short-Term Debt — 581 Current Liability—Royalty Obligation 1,600 1,358 Current Liability—Excess Royalty Payment Due 592 691 Deferred Revenue 846 543 Total Current Liabilities 40,631 46,346 NON-CURRENT LIABILITIES Long-Term Debt, net of current portion 18,978 19,044 Lease Liabilities, net of current portion 2,107 1,535 Grant Deferred Revenue 1,061 1,090 Royalty Obligation, net of current portion 354 1,106 Income Taxes Payable 684 684 Deferred Tax Liabilities — 40 Other Long-Term Liability 138 — TOTAL LIABILITIES 63,953 69,845 SHAREHOLDERS' EQUITY Preferred Stock, $ 10 Par Value, Authorized 100,000 shares, None Issued — — Common Stock, $ 0.05 Par Value, Authorized 13,000,000 shares; Issued 11,053,490 and 10,936,220 shares at October 31, 2025 and January 31, 2025, respectively 553 547 Additional Paid-in Capital 65,681 64,215 Retai

View Full Filing

View this 10-Q filing on SEC EDGAR